checkAd
    Startseite > Aktien > Lisata Therapeutics > Nachrichten
    Lisata Therapeutics Aktie
    2,7600
     
    EUR
    -4,83 %
    -0,1400 EUR
    Letzter Kurs 31.05.24 Tradegate
    2,7400
     
    EUR
    600 STK
    Geldkurs 19:15:18
    2,8800
     
    EUR
    600 STK
    Briefkurs 19:15:18
    ISIN: US1280583022 · WKN: A3DWGC · SYM: 8NE · USA

    Neueste Nachrichten

    Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events
    28.05.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer
    20.05.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    09.05.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events
    08.05.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024
    02.05.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
    23.04.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma
    09.04.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor Events
    03.04.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of Osteosarcoma
    21.03.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
    29.02.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics to Host Year-End 2023 Conference Call on Thursday, February 29, 2024 at 4: 30 p.m. Eastern Time
    22.02.24 · globenewswire · Lisata Therapeutics
    Lisata Therapeutics to Present at BIO CEO & Investor Conference
    20.02.24 · globenewswire · Lisata Therapeutics